Filing Details
- Accession Number:
- 0001375151-19-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-01 20:43:42
- Reporting Period:
- 2019-06-27
- Accepted Time:
- 2019-07-01 20:43:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1375151 | Zogenix Inc. | ZGNX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355576 | P Michael Smith | C/O Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville CA 94608 | Evp, Cfo, Treasurer & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-27 | 15,000 | $10.35 | 16,387 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-06-27 | 15,000 | $46.32 | 1,387 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-27 | 15,000 | $0.00 | 15,000 | $10.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
120,000 | 2027-01-16 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan previously entered into by the reporting person.
- Includes 127 shares purchased under the Company's Employee Stock Purchase Plan which were not previously reported pursuant to the exemption under Rule 16b-3(c).
- Option vests over four years at the rate of 25% on January 16, 2018, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months, subject to the reporting person's continued employment or service to the Company on each vesting date.